Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages

Oncogene volume 24, pages 5278–5286 (2005)Cite this article

Abstract

Gene translocations that repress the function of the Runx1 transcription factor play a critical role in the development of myeloid leukemia. In this report, we demonstrate that Runx1 precisely regulates c-fms (CSF-1 receptor) gene expression. Runx1 controlled expression by binding to multiple sites within the mouse c-fms gene, allowing interaction between promoter and downstream enhancer elements. The runx1 and c-fms genes showed an identical pattern of expression in mature macrophages. Runx1 expression was repressed in CSF-1 stimulated, proliferating bone marrow-derived macrophages (BMM) and significantly increased in quiescent, CSF-1 starved cells. The RAW264.7 and Mono-Mac-6, macrophage-like cell lines expressed low levels of Runx1 and both showed growth arrest and cell death with ectopic expression of Runx1. The EM-3 cell line, which represents an early myeloid progenitor cell line, showed growth arrest with Runx1 expression in the absence of any detectable changes in cell differentiation. These findings suggest that Runx1 regulates growth and survival of myeloid cells and provide a novel insight into the role of Runx family gene translocations in leukemogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Adya N, Stacy T, Speck NA and Liu PP . (1998). Mol. Cell. Biol., 18, 7432–7443.

  • Castilla LH, Garrett L, Adya N, Orlic D, Dutra A, Anderson S, Owens J, Eckhaus M, Bodine D and Liu PP . (1999). Nat. Genet, 23, 144–146.

  • Cecchini MG, Hofstetter W, Halasy J, Wetterwald A and Felix R . (1997). Mol. Reprod. Dev., 46, 75–83; discussion 83–84.

  • Cochet O, Kenigsberg M, Delumeau I, Duchesne M, Schweighoffer F, Tocque B and Teillaud JL . (1998). Mol. Immunol., 35, 1097–1110.

  • Dai XM, Ryan GR, Hapel AJ, Dominguez MG, Russell RG, Kapp S, Sylvestre V and Stanley ER . (2002). Blood, 99, 111–120.

  • Downing JR, Head DR, Curcio-Brint AM, Hulshof MG, Motroni TA, Raimondi SC, Carroll AJ, Drabkin HA, Willman C and Theil KS et al. (1993). Blood, 81, 2860–2865.

  • Follows GA, Tagoh H, Lefevre P, Hodge D, Morgan GJ and Bonifer C . (2003). Embo. J., 22, 2798–2809.

  • Fukamachi H and Ito K . (2004). Oncogene, 23, 4330–4335.

  • Heibert SW, Lutterbach B, Durst K, Wang L, Linggi B, Wu S, Wood L, Amann J, King D and Hou Y . (2001). Cancer Chemother. Pharmacol., 48 (Suppl 1), S31–S34.

  • Himes SR, Tagoh H, Goonetilleke N, Sasmono T, Oceandy D, Clark R, Bonifer C and Hume DA . (2001). J. Leukoc. Biol., 70, 812–820.

  • Hume DA, Yue X, Ross IL, Favot P, Lichanska A and Ostrowski MC . (1997). Mol. Reprod. Dev., 46, 46–52; discussion 52–53.

  • Ichikawa M, Asai T, Saito T, Yamamoto G, Seo S, Yamazaki I, Yamagata T, Mitani K, Chiba S, Hirai H, Ogawa S and Kurokawa M . (2004). Nat. Med., 10, 299–304.

  • Levanon D, Glusman G, Bettoun D, Ben-Asher E, Negreanu V, Bernstein Y, Harris-Cerruti C, Brenner O, Eilam R, Lotem J, Fainaru O, Goldenberg D, Pozner A, Woolf E, Xiao C, Yarmus M and Groner Y . (2003). Blood Cells Mol. Dis., 30, 161–163.

  • Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC and Ito Y . (2002). Cell, 109, 113–124.

  • Linggi B, Muller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP and Hiebert SW . (2002). Nat. Med., 8, 743–750.

  • Lutterbach B and Hiebert SW . (2000). Gene, 245, 223–235.

  • Maruyama F, Yang P, Stass SA, Cork A, Freireich EJ, Lee MS and Chang KS . (1993). Cancer Res., 53, 4449–4451.

  • Meyers S, Lenny N and Hiebert SW . (1995). Mol. Cell. Biol., 15, 1974–1982.

  • Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N and Ohki M . (1993). Embo. J., 12, 2715–2721.

  • Mulloy JC, Cammenga J, MacKenzie KL, Berguido FJ, Moore MA and Nimer SD . (2002). Blood, 99, 15–23.

  • Okuda T, Cai Z, Yang S, Lenny N, Lyu CJ, van Deursen JM, Harada H and Downing JR . (1998). Blood, 91, 3134–3143.

  • Okuda T, van Deursen J, Hiebert SW, Grosveld G and Downing JR . (1996). Cell, 84, 321–330.

  • Petrovick MS, Hiebert SW, Friedman AD, Hetherington CJ, Tenen DG and Zhang DE . (1998). Mol. Cell. Biol., 18, 3915–3925.

  • Sasaki K, Yagi H, Bronson RT, Tominaga K, Matsunashi T, Deguchi K, Tani Y, Kishimoto T and Komori T . (1996). Proc. Natl. Acad. Sci. USA, 93, 12359–12363.

  • Sasmono RT, Oceandy D, Pollard JW, Tong W, Pavli P, Wainwright BJ, Ostrowski MC, Himes SR and Hume DA . (2003). Blood, 101, 1155–1163.

  • Satake M, Inuzuka M, Shigesada K, Oikawa T and Ito Y . (1992). Jpn J. Cancer Res., 83, 714–722.

  • Sawyers CL . (1999). N. Engl. J. Med., 340, 1330–1340.

  • Sudo T, Nishikawa S, Ogawa M, Kataoka H, Ohno N, Izawa A and Hayashi S . (1995). Oncogene, 11, 2469–2476.

  • Tagoh H, Himes R, Clarke D, Leenen PJ, Riggs AD, Hume D and Bonifer C . (2002). Genes Dev., 16, 1721–1737.

  • Thompson PW, Lucas GS, Davies MF and Whittaker JA . (1991). Cancer Genet. Cytogenet., 55, 269–271.

  • Tracey WD and Speck NA . (2000). Semin. Cell. Dev. Biol., 11, 337–342.

  • Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH and Speck NA . (1996). Proc. Natl. Acad. Sci. USA, 93, 3444–3449.

  • Wang SW and Speck NA . (1992). Mol. Cell. Biol., 12, 89–102.

  • Yang Y, Wang W, Cleaves R, Zahurak M, Cheng L, Civin CI and Friedman AD . (2002). Cancer Res., 62, 2232–2235.

  • Zhang DE, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, Chen HM, Hiebert SW and Tenen DG . (1996a). Mol. Cell. Biol., 16, 1231–1240.

  • Zhang DE, Hohaus S, Voso MT, Chen HM, Smith LT, Hetherington CJ and Tenen DG . (1996b). Curr. Top Microbiol. Immunol., 211, 137–147.

Download references

Author information

Authors and Affiliations

  1. CRC for Chronic Inflammatory Disease, Institute for Molecular Biosciences, Queensland Biosciences Precinct, Bldg. 80, Services Rd., University of Queensland, Brisbane, 4072, Queensland, Australia

    Stewart R Himes, Stephen Cronau, Christine Mulford & David A Hume

Authors
  1. Stewart R Himes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen Cronau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christine Mulford
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David A Hume
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David A Hume.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Himes, S., Cronau, S., Mulford, C. et al. The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages. Oncogene 24, 5278–5286 (2005). https://doi.org/10.1038/sj.onc.1208657

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208657

Keywords

This article is cited by

Search

Advanced search

Quick links